These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 30428334)

  • 21. Intranasal Delivery of Exendin-4 Confers Neuroprotective Effect Against Cerebral Ischemia in Mice.
    Zhang H; Meng J; Zhou S; Liu Y; Qu D; Wang L; Li X; Wang N; Luo X; Ma X
    AAPS J; 2016 Mar; 18(2):385-94. PubMed ID: 26689204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intranasal Delivery of Apelin-13 Is Neuroprotective and Promotes Angiogenesis After Ischemic Stroke in Mice.
    Chen D; Lee J; Gu X; Wei L; Yu SP
    ASN Neuro; 2015; 7(5):. PubMed ID: 26391329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The erythropoietin-derived peptide MK-X and erythropoietin have neuroprotective effects against ischemic brain damage.
    Yoo SJ; Cho B; Lee D; Son G; Lee YB; Soo Han H; Kim E; Moon C; Moon C
    Cell Death Dis; 2017 Aug; 8(8):e3003. PubMed ID: 28817120
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intranasal delivery of progesterone after transient ischemic stroke decreases mortality and provides neuroprotection.
    Fréchou M; Zhang S; Liere P; Delespierre B; Soyed N; Pianos A; Schumacher M; Mattern C; Guennoun R
    Neuropharmacology; 2015 Oct; 97():394-403. PubMed ID: 26079443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lectin-conjugated PEG-PLA nanoparticles: preparation and brain delivery after intranasal administration.
    Gao X; Tao W; Lu W; Zhang Q; Zhang Y; Jiang X; Fu S
    Biomaterials; 2006 Jun; 27(18):3482-90. PubMed ID: 16510178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intranasal deferoxamine provides increased brain exposure and significant protection in rat ischemic stroke.
    Hanson LR; Roeytenberg A; Martinez PM; Coppes VG; Sweet DC; Rao RJ; Marti DL; Hoekman JD; Matthews RB; Frey WH; Panter SS
    J Pharmacol Exp Ther; 2009 Sep; 330(3):679-86. PubMed ID: 19509317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibiting pro-death NMDA receptor signaling dependent on the NR2 PDZ ligand may not affect synaptic function or synaptic NMDA receptor signaling to gene expression.
    Martel MA; Soriano FX; Baxter P; Rickman C; Duncan R; Wyllie DJ; Hardingham GE
    Channels (Austin); 2009; 3(1):12-5. PubMed ID: 19221512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intranasal delivery of bFGF with nanoliposomes enhances in vivo neuroprotection and neural injury recovery in a rodent stroke model.
    Zhao YZ; Lin M; Lin Q; Yang W; Yu XC; Tian FR; Mao KL; Yang JJ; Lu CT; Wong HL
    J Control Release; 2016 Feb; 224():165-175. PubMed ID: 26774220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective effects of the angiotensin II AT
    Bennion DM; Jones CH; Dang AN; Isenberg J; Graham JT; Lindblad L; Domenig O; Waters MF; Poglitsch M; Sumners C; Steckelings UM
    Clin Sci (Lond); 2018 Mar; 132(5):581-593. PubMed ID: 29500223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TFP5 peptide, derived from CDK5-activating cofactor p35, provides neuroprotection in early-stage of adult ischemic stroke.
    Ji YB; Zhuang PP; Ji Z; Wu YM; Gu Y; Gao XY; Pan SY; Hu YF
    Sci Rep; 2017 Jan; 7():40013. PubMed ID: 28045138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dual targeted nanocarrier for brain ischemic stroke treatment.
    Zhao Y; Jiang Y; Lv W; Wang Z; Lv L; Wang B; Liu X; Liu Y; Hu Q; Sun W; Xu Q; Xin H; Gu Z
    J Control Release; 2016 Jul; 233():64-71. PubMed ID: 27142584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Applications of Liposomal Drug Delivery Systems to Develop Neuroprotective Agents for the Treatment of Ischemic Stroke.
    Fukuta T; Ishii T; Asai T; Oku N
    Biol Pharm Bull; 2019; 42(3):319-326. PubMed ID: 30828062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tat-NR2B9c prevents excitotoxic neuronal superoxide production.
    Chen Y; Brennan-Minnella AM; Sheth S; El-Benna J; Swanson RA
    J Cereb Blood Flow Metab; 2015 May; 35(5):739-42. PubMed ID: 25669908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuron protection as a therapeutic target in acute ischemic stroke.
    Tuttolomondo A; Di Sciacca R; Di Raimondo D; Arnao V; Renda C; Pinto A; Licata G
    Curr Top Med Chem; 2009; 9(14):1317-34. PubMed ID: 19849659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intranasal Delivery of Targeted Nanoparticles Loaded With miR-132 to Brain for the Treatment of Neurodegenerative Diseases.
    Su Y; Sun B; Gao X; Dong X; Fu L; Zhang Y; Li Z; Wang Y; Jiang H; Han B
    Front Pharmacol; 2020; 11():1165. PubMed ID: 32848773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroprotection after status epilepticus by targeting protein interactions with postsynaptic density protein 95.
    Dykstra CM; Ratnam M; Gurd JW
    J Neuropathol Exp Neurol; 2009 Jul; 68(7):823-31. PubMed ID: 19535989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tramiprosate protects neurons against ischemic stroke by disrupting the interaction between PSD95 and nNOS.
    Wu S; Yue Y; Tian H; Tao L; Wang Y; Xiang J; Wang S; Ding H
    Neuropharmacology; 2014 Aug; 83():107-17. PubMed ID: 24769446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stroke injury induced by distal middle cerebral artery occlusion is resistant to N-methyl-d-aspartate receptor antagonism in FVB/NJ mice.
    Liu CW; Liao KH; Wu CM; Chen HY; Wang EY; Lai TW
    Neuroreport; 2021 Sep; 32(13):1122-1127. PubMed ID: 34284452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of the PSD95 inhibitor Tat-NR2B9c in mice requires dose translation between species.
    Teves LM; Cui H; Tymianski M
    J Cereb Blood Flow Metab; 2016 Mar; 36(3):555-61. PubMed ID: 26661213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted delivery of etoposide, carmustine and doxorubicin to human glioblastoma cells using methoxy poly(ethylene glycol)‑poly(ε‑caprolactone) nanoparticles conjugated with wheat germ agglutinin and folic acid.
    Kuo YC; Chang YH; Rajesh R
    Mater Sci Eng C Mater Biol Appl; 2019 Mar; 96():114-128. PubMed ID: 30606517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.